Literature DB >> 9802888

Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.

W J Murphy1, L A Welniak, D D Taub, R H Wiltrout, P A Taylor, D A Vallera, M Kopf, H Young, D L Longo, B R Blazar.   

Abstract

Graft-versus-host disease (GVHD), in which immunocompetent donor cells attack the host, remains a major cause of morbidity after allogeneic bone marrow transplantation (BMT). To understand the role of cytokines in the pathobiology of GVHD, we used cytokine knockout (KO) mice as a source of donor T cells. Two different MHC-disparate strain combinations were examined: BALB/c (H2(d)) donors into lethally irradiated C57BL/6 (H2(b)) recipients or C57BL/6 (H2(b)) donors into B10.BR (H2(k)) recipients. Donor cells were from mice in which either the interferon-gamma (IFN-gamma) or the IL-4 gene was selectively disrupted to understand the role of these cytokines in acute GVHD. In both strain combinations the same pattern was noted with regard to GVHD onset and morbidity. All mice exhibited the classic signs of acute GVHD: weight loss with skin, gut, and liver pathology resulting in morbidity and mortality. Surprisingly, donor cells obtained from mice lacking IFN-gamma gave rise to accelerated morbidity from GVHD when compared with cells from wild-type control donors. Similar results were obtained using normal donors when neutralizing antibodies to IFN-gamma were administered immediately after the BMT. These results suggest that IFN-gamma plays a role in protection from acute GVHD. In marked contrast, cells obtained from IL-4 KO mice resulted in protection from GVHD compared with control donors. Splenocytes from IFN KO mice stimulated with a mitogen proliferated to a significantly greater extent and produced more IL-2 compared with splenocytes obtained from IL-4 KO or control mice. Additionally, there was increased IL-2 production in the spleens of mice undergoing GVHD using IFN-gamma KO donors. These results therefore indicate, with regard to the TH1/ TH2 cytokine paradigm, the absence of a TH1-type cytokine can be deleterious in acute GVHD, whereas absence of a TH2 cytokine can be protective.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9802888      PMCID: PMC509122          DOI: 10.1172/JCI3906

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

Review 1.  The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation.

Authors:  W J Murphy; D L Longo
Journal:  Immunol Rev       Date:  1997-06       Impact factor: 12.988

2.  Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versus-host disease.

Authors:  W Krenger; K R Cooke; J M Crawford; S T Sonis; R Simmons; L Pan; J Delmonte; M Karandikar; J L Ferrara
Journal:  Transplantation       Date:  1996-11-15       Impact factor: 4.939

Review 3.  The Th1/Th2 paradigm and the allograft response.

Authors:  T B Strom; P Roy-Chaudhury; R Manfro; X X Zheng; P W Nickerson; K Wood; A Bushell
Journal:  Curr Opin Immunol       Date:  1996-10       Impact factor: 7.486

4.  Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines.

Authors:  G R Hill; J M Crawford; K R Cooke; Y S Brinson; L Pan; J L Ferrara
Journal:  Blood       Date:  1997-10-15       Impact factor: 22.113

5.  Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma.

Authors:  A Billiau; H Heremans; F Vandekerckhove; R Dijkmans; H Sobis; E Meulepas; H Carton
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

6.  Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarizes the cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease.

Authors:  E Williamson; P Garside; J A Bradley; I A More; A M Mowat
Journal:  J Immunol       Date:  1997-08-01       Impact factor: 5.422

7.  Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice. Recipient environment alters graft rejection.

Authors:  A Räisänen-Sokolowski; P L Mottram; T Glysing-Jensen; A Satoskar; M E Russell
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

8.  Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells.

Authors:  M Sykes; M L Romick; D H Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

9.  Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors.

Authors:  C A Ellison; J M Fischer; K T HayGlass; J G Gartner
Journal:  J Immunol       Date:  1998-07-15       Impact factor: 5.422

10.  An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease.

Authors:  B M Segal; B K Dwyer; E M Shevach
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

View more
  76 in total

1.  Revisiting graft-versus-host disease models of autoimmunity: new insights in immune regulatory processes.

Authors:  W J Murphy
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

2.  Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes.

Authors:  Keli L Hippen; Christoph Bucher; Dawn K Schirm; Amanda M Bearl; Ty Brender; Kathy A Mink; Kimberly S Waggie; Regis Peffault de Latour; Anne Janin; Julie M Curtsinger; Stacey R Dillon; Jeffrey S Miller; Gerard Socie; Bruce R Blazar
Journal:  Blood       Date:  2011-11-10       Impact factor: 22.113

3.  IFN-γ promotes graft-versus-leukemia effects without directly interacting with leukemia cells in mice after allogeneic hematopoietic cell transplantation.

Authors:  Yanping Yang; Hui Wang; Hui Yu; Beow Yong Yeap; Tingting Liang; Guanjun Wang; Tao Cheng; Yong-Guang Yang
Journal:  Blood       Date:  2011-08-11       Impact factor: 22.113

Review 4.  Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.

Authors:  Young-June Kim; Hal E Broxmeyer
Journal:  Crit Rev Oncol Hematol       Date:  2010-08-19       Impact factor: 6.312

5.  Attenuation of acute graft-versus-host disease in the absence of the transcription factor RORγt.

Authors:  LeShara M Fulton; Michael J Carlson; James M Coghill; Laura E Ott; Michelle L West; Angela Panoskaltsis-Mortari; Dan R Littman; Bruce R Blazar; Jonathan S Serody
Journal:  J Immunol       Date:  2012-07-09       Impact factor: 5.422

6.  Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation.

Authors:  Brian G Engelhardt; Sophie Paczesny; Dae Kwang Jung; Etienne Daguindau; Madan Jagasia; Bipin N Savani; Wichai Chinratanalab; Robert F Cornell; Stacey Goodman; John P Greer; Adetola A Kassim; Salyka Sengsayadeth; Sandra M Yoder; Michael T Rock; James E Crowe
Journal:  Haematologica       Date:  2016-01-27       Impact factor: 9.941

7.  Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activity.

Authors:  Bradley W Blaser; Noah R Schwind; Seth Karol; Dennis Chang; Samuel Shin; Sameek Roychowdhury; Brian Becknell; Amy K Ferketich; Donna F Kusewitt; Bruce R Blazar; Michael A Caligiuri
Journal:  Blood       Date:  2006-06-06       Impact factor: 22.113

Review 8.  Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers.

Authors:  Arnab Ghosh; Amanda M Holland; Marcel R M van den Brink
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

9.  In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations.

Authors:  Michael J Carlson; Michelle L West; James M Coghill; Angela Panoskaltsis-Mortari; Bruce R Blazar; Jonathan S Serody
Journal:  Blood       Date:  2008-10-28       Impact factor: 22.113

Review 10.  Genetics of allogeneic hematopoietic cell transplantation. Role of HLA matching, functional variation in immune response genes.

Authors:  John A Hansen; Effie W Petersdorf; Ming-Tseh Lin; Steven Wang; Jason W Chien; Barry Storer; Paul J Martin
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.